NMDA Antagonist Succeeds for Depression; Green Light for Pain

]]>(MedPage Today) -- The novel NMDA receptor antagonist AXS-05--bupropion and dextromethorphan oral tablets--succeeded at improving depressive symptoms in the 6-week phase III GEMINI trial, Axsome Therapeutics announced.In related news...